| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |